Ocular Therapeutix is dedicated to be the leading developer of sustained ophthalmic therapies with proprietary tailored hydrogels to improve patient experience and outcomes.

Drug-eluting punctum plugs are investigational new drugs and not commercially available in the United States.

1PMA P130004